Clinically Meaningful Improvements in St George's Respiratory Questionnaire Score with Tezepelumab Versus Placebo in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study

被引：0
|
作者：
Kraft, M. [1 ]
Corren, J. [2 ]
Ambrose, C. S. [3 ]
Cook, B. [3 ]
Clarke, N. [4 ]
Hunter, G. [5 ]
Molfino, N. [6 ]
Ponnarambil, S. [7 ]
机构：
[1] Univ Arizona, Hlth Sci Ctr, Tucson, AZ USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Gaithersburg, MD USA
[4] AstraZeneca, Patient Centered Sci, Resp & Immunol, Gaithersburg, MD USA
[5] AstraZeneca, Late Stage Dev, Resp & Immunol, BioPharmaceut R&D,Biometr, Cambridge, England
[6] Amgen Inc, Global Dev, Thousand Oaks, CA USA
[7] Astrazeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Cambridge, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2360
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
    Corren, J.
    Karpefors, M.
    Hellqvist, A.
    Parnes, J. R.
    [J]. ALLERGY, 2020, 75 : 17 - 18
  • [42] EFFECT OF TEZEPELUMAB ON EXACERBATIONS IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA, ACCORDING TO BASELINE BODY MASS INDEX: RESULTS FROM THE PHASE 2B PATHWAY STUDY
    Ambrose, C. S.
    Colice, G.
    Salapa, K.
    Parnes, J. R.
    Corren, J.
    [J]. THORAX, 2021, 76 : A83 - A83
  • [43] THE EFFECT OF TEZEPELUMAB ON EXACERBATIONS IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA ACCORDING TO BASELINE INHALED CORTICOSTEROID DOSE: RESULTS FROM THE PHASE 2B PATHWAY STUDY
    Corren, Jonathan
    Ambrose, Christopher
    Salapa, Kinga
    Parnes, Jane
    Colice, Gene
    [J]. CHEST, 2020, 158 (04) : 30A - 31A
  • [44] Effect of Tezepelumab on Exacerbations in Patients with Severe, Uncontrolled Asthma, According to Baseline Body Mass Index: Results from the Phase 2b PATHWAY Study
    Ambrose, Chris
    Colice, Gene
    Salapa, Kinga
    Parnes, Jane
    Corren, Jonathan
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB25 - AB25
  • [45] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Andrew Menzies-Gow
    Gene Colice
    Janet M. Griffiths
    Gun Almqvist
    Sandhia Ponnarambil
    Primal Kaur
    Gennaro Ruberto
    Karin Bowen
    Åsa Hellqvist
    May Mo
    Esther Garcia Gil
    [J]. Respiratory Research, 21
  • [46] The Impact of Tezepelumab on Hospitalization and Emergency Department Visits in Patients with Severe Uncontrolled Asthma: Results from the Pathway Phase 2b Trial
    Corren, J.
    Chen, S.
    Callan, L.
    Garcia Gil, E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [47] EPRATUZUMAB DEMONSTRATES CLINICALLY MEANINGFUL IMPROVEMENTS IN PATIENTS WITH MODERATE-TO-SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM EMBLEM™, A PHASE IIB STUDY
    Gordon, Caroline
    Kalunian, K.
    Petri, M.
    Strand, V.
    Kilgallen, B.
    Barry, A.
    Wallace, D.
    [J]. RHEUMATOLOGY, 2012, 51 : 25 - 25
  • [48] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Menzies-Gow, Andrew
    Colice, Gene
    Griffiths, Janet M.
    Almqvist, Gun
    Ponnarambil, Sandhia
    Kaur, Primal
    Ruberto, Gennaro
    Bowen, Karin
    Hellqvist, Asa
    Mo, May
    Garcia Gil, Esther
    [J]. RESPIRATORY RESEARCH, 2020, 21 (01)
  • [49] LOW-DOSE SOLUMATRIX MELOXICAM RESULTS IN CLINICALLY MEANINGFUL IMPROVEMENTS IN PAIN IN A PHASE 3 STUDY OF PATIENTS WITH OSTEOARTHRITIS
    Altman, R.
    Hochberg, M.
    Kivitz, A.
    Gibofsky, A.
    Solorio, D.
    Young, C.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S419 - S420
  • [50] IMPROVEMENTS IN HEALTH STATUS WITH REVEFENACIN: A POST HOC ANALYSIS OF ST GEORGE'S RESPIRATORY QUESTIONNAIRE IN PATIENT SUBGROUPS FROM REPLICATE PHASE 3 TRIALS
    Siler, Thomas
    Donohue, James
    Lombardi, David
    Crater, Glenn
    [J]. CHEST, 2020, 158 (04) : 1750A - 1751A
12345